PAMELA LOONEY: Open Payments
NPI 1548829021 · GRUNDY, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$135 in 8 payments from 4 companies in 2025. Trend: 2023 $156 · 2024 $170 · 2025 $135
Food & beverage: $135
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $80 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: Ozempic, Rybelsus, CAPLYTA, FARXIGA, TRELEGY ELLIPTA, Wegovy.
Industry payments across VA — which companies pay providers there.
